What is he best known for?
The fields of study he is best known for:
- Gene
- Immune system
- Internal medicine
Roland W. Herzog mainly focuses on Immunology, Genetic enhancement, Factor IX, Immune system and Transgene.
Antibody is the focus of his Immunology research.
His biological study spans a wide range of topics, including Vector, Internal medicine, Partial thromboplastin time and Null allele.
While the research belongs to areas of Factor IX, Roland W. Herzog spends his time largely on the problem of Intramuscular injection, intersecting his research to questions surrounding Adenoviridae.
His study in the field of Immune tolerance, Innate immune system and T cell also crosses realms of Cold storage.
The concepts of his Transgene study are interwoven with issues in Molecular biology, Gene product and Virology.
His most cited work include:
- Evidence for gene transfer and expression of factor IX in haemophilia B patients treated with an AAV vector (936 citations)
- AAV-mediated factor IX gene transfer to skeletal muscle in patients with severe hemophilia B. (622 citations)
- LONG-TERM CORRECTION OF CANINE HEMOPHILIA B BY GENE TRANSFER OF BLOOD COAGULATION FACTOR IX MEDIATED BY ADENO-ASSOCIATED VIRAL VECTOR (522 citations)
What are the main themes of his work throughout his whole career to date?
His primary scientific interests are in Immunology, Immune system, Genetic enhancement, Factor IX and Immune tolerance.
His Immunology research includes themes of Genetic transfer and Adeno-associated virus.
His research in Immune system intersects with topics in Cytotoxic T cell, Bioinformatics, Antigen and Cell biology.
His Genetic enhancement research integrates issues from Transgene, Virology, Vector, Coagulation and Viral vector.
The various areas that Roland W. Herzog examines in his Transgene study include Molecular biology, Gene expression and Transduction.
His Factor IX study combines topics in areas such as Mutation, Intramuscular injection, Gene delivery and Skeletal muscle.
He most often published in these fields:
- Immunology (53.12%)
- Immune system (48.05%)
- Genetic enhancement (50.39%)
What were the highlights of his more recent work (between 2017-2020)?
- Genetic enhancement (50.39%)
- Immune system (48.05%)
- Bioinformatics (12.11%)
In recent papers he was focusing on the following fields of study:
His primary areas of study are Genetic enhancement, Immune system, Bioinformatics, Cell biology and Coagulation.
His Genetic enhancement research is multidisciplinary, incorporating perspectives in Vector, Internal medicine, Oncology and Chimera.
His Immune system research entails a greater understanding of Immunology.
His study on Bioinformatics also encompasses disciplines like
- Clotting factor which is related to area like Virus,
- MEDLINE together with Immunogenicity, Capsid and Virology.
His Cell biology research incorporates elements of Adeno-associated virus, Hepatocyte, Green fluorescent protein, Innate immune system and Antigen presentation.
His work in Adeno-associated virus tackles topics such as Immune tolerance which are related to areas like Genetic disorder, Factor IX and Isoantibodies.
Between 2017 and 2020, his most popular works were:
- Update on clinical gene therapy for hemophilia (46 citations)
- Update on clinical gene therapy for hemophilia (46 citations)
- A Molecular Revolution in the Treatment of Hemophilia. (27 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Immune system
- Internal medicine
His main research concerns Genetic enhancement, Immune system, Bioinformatics, Coagulation and Cell biology.
His Genetic enhancement research is multidisciplinary, incorporating elements of Genetically modified organism, Hepatitis C virus, Hepatocyte, Liver disease and In vivo.
His Immune system study is concerned with the larger field of Immunology.
His research integrates issues of Protein replacement therapy, Clotting factor, Anticoagulant and Small interfering RNA in his study of Bioinformatics.
He combines subjects such as Dendritic cell, CD8, Cytotoxic T cell, Antigen presentation and Innate immune system with his study of Cell biology.
Roland W. Herzog interconnects Vector, Hemophilias, Cell therapy and Adoptive cell transfer in the investigation of issues within Viral vector.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
